跳至主要内容
临床试验/IRCT20170608034390N15
IRCT20170608034390N15招募中3 期

Evaluating the Efficacy of Eicosapentaenoic Acid compared to placebo on Modified Rankin Scale and Inflammatory Biomarkers in Patients with Ischemic Stroke: A Randomized Controlled Trial.

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients older than 18 years
  • Ischemic stroke
  • Hospitalized in neurology ward

排除标准

  • Patients that are under treatment with Alteplase
  • Patients with the history of allergy to fish liver oil and its derivatives.
  • Patients with platelet level Count < 50,000.
  • Patients with active bleeding.
  • Patients with active systemic bleeding disorders.
  • Patients with severe stroke (NIHSS score >20).

研究者

相似试验

Evaluating the efficacy of eicosapentanoic acid on ... | 临床试验